The mechanism of baicalein in bone pain in cancer was studied by Hu et al. [27], who reported that the compound might be effective by inhibiting P-P38 and p-JNK MAP kinase signaling pathway, while the protective analgesic effect may be through the inhibition of various cytokines like IL6. The gene discussed is MAPK8; the disease is cancer.